How VETIGEL Supported Luna’s Recovery After a Severe Injury
Posted by Nicolas Arreste onZomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel® Hemostatic Gel in the Animal Health Market
Posted by Nicolas Arreste onCresilon Announces Partnership for VETIGEL with VerticalVet
Posted by Nicolas Arreste onPartnership provides VerticalVet’s 1,800 veterinary members with access to market-leading hemostatic agent NEW YORK (June 11, 2024) — Cresilon Inc. (“Cresilon”), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has...
VETIGEL Now Available in the U.K. and Across Europe
Posted by Nicolas Arreste onRevolutionary hemostatic gel for veterinary surgeons available in U.K. and across Europe through Veterinary Instrumentation and distribution partners NEW YORK (May 20, 2024) — Cresilon Inc. (“Cresilon”), a Brooklyn-based biotechnology company focused on hemostatic medical...